An already-ailing alcohol industry might have a new problem: GLP-1s

Posted
About 10 million people in the U.S. are currently on a branded GLP-1. (Amie Johnson via Unsplash)

GLP-1 medications like Ozempic might have impacts outside of people’s weight-loss.



Continue reading at syracuse.com »